The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination

Oncogene

Volumn 36, Issue 21, 2017, Pages 3002-3014

  Crosas Molist, E ^a,b   Bertran, E ^a   Rodriguez Hernandez, I ^b   Herraiz, C ^b,d   Cantelli, G ^b   Fabra, A ^a   Sanz Moreno, V ^b   Fabregat, I ^a,c  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN LIGHT CHAIN 2; PROTEIN CDC42; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; RHO FACTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UVOMORULIN; NOX4 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CANCER PROGNOSIS; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE DELETION; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; MESENCHYME CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TUMOR INVASION; CELL MOTION; DOWN REGULATION; GENE EXPRESSION PROFILING; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ACTOMYOSIN; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER NEOPLASMS; NADPH OXIDASE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS;

EID: 85004038621     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2016.454     Document Type: Article

References (61)

1. Friedl P, Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011; 147: 992-1009.
2. Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E. Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 2009; 11: 1287-1296.
3. Lorentzen A, Bamber J, Sadok A, Elson-Schwab I, Marshall CJ. An ezrin-rich, rigid uropod-like structure directs movement of amoeboid blebbing cells. J Cell Sci 2011; 124: 1256-1267.
4. Cantelli G, Orgaz JL, Rodriguez-Hernandez I, Karagiannis P, Maiques O, Matias-Guiu X et al. TGF-beta-induced transcription sustains amoeboid melanoma migration and dissemination. Curr Biol 2015; 25: 2899-2914.
5. Sanz-Moreno V. Tumour invasion: a new twist on Rac-driven mesenchymal migration. Curr Biol 2012; 22: R449-R451.
6. Calvo F, Sanz-Moreno V, Agudo-Ibanez L, Wallberg F, Sahai E, Marshall CJ et al. RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation. Nat Cell Biol 2011; 13: 819-826.
7. Gadea G, Sanz-Moreno V, Self A, Godi A, Marshall CJ. DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells. Curr Biol 2008; 18: 1456-1465.
8. Sahai E, Marshall CJ. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 2003; 5: 711-719.
9. Ito M, Nakano T, Erdodi F, Hartshorne DJ. Myosin phosphatase: structure, regulation and function. Mol Cell Biochem 2004; 259: 197-209.
10. Ahn J, Sanz-Moreno V, Marshall CJ. The metastasis gene NEDD9 product acts through integrin beta3 and Src to promote mesenchymal motility and inhibit amoeboid motility. J Cell Sci 2012; 125: 1814-1826.
11. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell 2008; 135: 510-523.
12. Sanz-Moreno V, Gaggioli C, Yeo M, Albrengues J, Wallberg F, Viros A et al. ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell 2011; 20: 229-245.
13. Herraiz C, Calvo F, Pandya P, Cantelli G, Rodriguez-Hernandez I, Orgaz JL et al. Reactivation of p53 by a cytoskeletal sensor to control the balance between DNA damage and tumor dissemination. J Natl Cancer Inst 2016; 108: 1-14.
14. Tozluoglu M, Tournier AL, Jenkins RP, Hooper S, Bates PA, Sahai E. Matrix geometry determines optimal cancer cell migration strategy and modulates response to interventions. Nat Cell Biol 2013; 15: 751-762.
15. Bergert M, Erzberger A, Desai RA, Aspalter IM, Oates AC, Charras G et al. Force transmission during adhesion-independent migration. Nat Cell Biol 2015; 17: 524-529.
16. Liu YJ, Le Berre M, Lautenschlaeger F, Maiuri P, Callan-Jones A, Heuze M et al. Confinement and low adhesion induce fast amoeboid migration of slow mesenchymal cells. Cell 2015; 160: 659-672.
17. Ruprecht V, Wieser S, Callan-Jones A, Smutny M, Morita H, Sako K et al. Cortical contractility triggers a stochastic switch to fast amoeboid cell motility. Cell 2015; 160: 673-685.
18. Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut 2014; 63: 844-855.
19. Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 2016; 150: 835-853.
20. Reichl P, Haider C, Grubinger M, Mikulits W. TGF-beta in epithelial to mesenchymal transition and metastasis of liver carcinoma. Curr Pharm Des 2012; 18: 4135-4147.
21. Thiery JP, Acloque H, Huang RYJ, Nieto AM. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
22. Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal 2014; 7: re8.
23. Nieto MA, Cano A. The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin Cancer Biol 2012; 22: 361-368.
24. Stanley A, Thompson K, Hynes A, Brakebusch C, Quondamatteo F. NADPH oxidase complex-derived reactive oxygen species, the actin cytoskeleton, and Rho GTPases in cell migration. Antioxid Redox Signal 2014; 20: 2026-2042.
25. Brown DI, Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med 2009; 47: 1239-1253.
26. Crosas-Molist E, Fabregat I. Role of NADPH oxidases in the redox biology of liver fibrosis. Redox Biol 2015; 6: 106-111.
27. Aoyama T, Paik YH, Watanabe S, Laleu B, Gaggini F, Fioraso-Cartier L et al. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatology 2012; 56: 2316-2327.
28. Carmona-Cuenca I, Roncero C, Sancho P, Caja L, Fausto N, Fernandez M et al. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J Hepatol 2008; 49: 965-976.
29. Crosas-Molist E, Bertran E, Sancho P, Lopez-Luque J, Fernando J, Sanchez A et al. The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression. Free Radic Biol Med 2014; 69: 338-347.
30. Lai KK, Shang S, Lohia N, Booth GC, Masse DJ, Fausto N et al. Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models. PLoS Genet 2011; 7: e1002147.
31. Ruiz-Ontanon P, Orgaz JL, Aldaz B, Elosegui-Artola A, Martino J, Berciano MT et al. Cellular plasticity confers migratory and invasive advantages to a population of glioblastoma-initiating cells that infiltrate peritumoral tissue. Stem Cells 2013; 31: 1075-1085.
32. Sadok A, Marshall CJ. Rho GTPases: masters of cell migration. Small GTPases 2014; 5: e29710.
33. Blaser H, Reichman-Fried M, Castanon I, Dumstrei K, Marlow FL, Kawakami K et al. Migration of zebrafish primordial germ cells: a role for myosin contraction and cytoplasmic flow. Dev Cell 2006; 11: 613-627.
34. Jacobelli J, Friedman RS, Conti MA, Lennon-Dumenil AM, Piel M, Sorensen CM et al. Confinement-optimized three-dimensional T cell amoeboid motility is modulated via myosin IIA-regulated adhesions. Nat Immunol 2010; 11: 953-961.
35. Smith BN, Bhowmick NA. Role of EMT in metastasis and therapy resistance. J Clin Med 2016; 5: 1-17.
36. Llovet JM, Hernandez-Gea V. Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design. Clin Cancer Res 2014; 20: 2072-2079.
37. Brandes RP, Weissmann N, Schroder K. Nox family NADPH oxidases: molecular mechanisms of activation. Free Radic Biol Med 2014; 76: 208-226.
38. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, Knaus UG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 2006; 18: 69-82.
39. Lambeth JD, Kawahara T, Diebold B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic Biol Med 2007; 43: 319-331.
40. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O et al. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 2007; 406: 105-114.
41. Boudreau HE, Casterline BW, Burke DJ, Leto TL. Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-beta-mediated migration of human lung and breast epithelial cells. Br J Cancer 2014; 110: 2569-2582.
42. Kim HJ, Magesh V, Lee JJ, Kim S, Knaus UG, Lee KJ. Ubiquitin C-terminal hydrolase- L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4. Oncotarget 2015; 6: 16287-16303.
43. Senturk S, Mumcuoglu M, Gursoy-Yuzugullu O, Cingoz B, Akcali KC, Ozturk M. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth. Hepatology 2010; 52: 966-974.
44. Yu JH, Zhu BM, Riedlinger G, Kang K, Hennighausen L. The liver-specific tumor suppressor STAT5 controls expression of the reactive oxygen species-generating enzyme NOX4 and the proapoptotic proteins PUMA and BIM in mice. Hepatology 2012; 56: 2375-2386.
45. Murray TV, Dong X, Sawyer GJ, Caldwell A, Halket J, Sherwood R et al. NADPH oxidase 4 regulates homocysteine metabolism and protects against acetaminophen-induced liver damage in mice. Free Radic Biol Med 2015; 89: 918-930.
46. Gregg JL, Turner RM 2nd, Chang G, Joshi D, Zhan Y, Chen L et al. NADPH oxidase NOX4 supports renal tumorigenesis by promoting the expression and nuclear accumulation of HIF2alpha. Cancer Res 2014; 74: 3501-3511.
47. Li J, Lan T, Zhang C, Zeng C, Hou J, Yang Z et al. Reciprocal activation between IL-6/STAT3 and NOX4/Akt signalings promotes proliferation and survival of nonsmall cell lung cancer cells. Oncotarget 2015; 6: 1031-1048.
48. Valdivia A, Duran C, San Martin A. The role of Nox-mediated oxidation in the regulation of cytoskeletal dynamics. Curr Pharm Des 2015; 21: 6009-6022.
49. de Rezende FF, Martins Lima A, Niland S, Wittig I, Heide H, Schroder K et al. Integrin alpha7beta1 is a redox-regulated target of hydrogen peroxide in vascular smooth muscle cell adhesion. Free Radic Biol Med 2012; 53: 521-531.
50. Fernandez I, Martin-Garrido A, Zhou DW, Clempus RE, Seidel-Rogol B, Valdivia A et al. Hic-5 mediates TGFbeta-Induced adhesion in vascular smooth muscle cells by a Nox4-dependent mechanism. Arterioscler Thromb Vasc Biol 2015; 35: 1198-1206.
51. Montenegro MF, Valdivia A, Smolensky A, Verma K, Taylor WR, San Martin A. Nox4-dependent activation of cofilin mediates VSMC reorientation in response to cyclic stretching. Free Radic Biol Med 2015; 85: 288-294.
52. Chan CH, Lee SW, Li CF, Wang J, Yang WL, Wu CY et al. Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat Cell Biol 2010; 12: 457-467.
53. Ha SY, Paik YH, Yang JW, Lee MJ, Bae H, Park CK. NADPH oxidase 1 and NADPH oxidase 4 have opposite prognostic effects for patients with hepatocellular carcinoma after hepatectomy. Gut Liver 2016; 10: 826-835.
54. Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 2015; 527: 186-191.
55. Le Gal K, Ibrahim MX, Wiel C, Sayin VI, Akula MK, Karlsson C et al. Antioxidants can increase melanoma metastasis in mice. Sci Transl Med 2015; 7: 308re308.
56. Zavattari P, Perra A, Menegon S, Kowalik MA, Petrelli A, Angioni MM et al. Nrf2, but not beta-catenin, mutation represents an early event in rat hepatocarcinogenesis. Hepatology 2015; 62: 851-862.
57. Fernando J, Malfettone A, Cepeda EB, Vilarrasa-Blasi R, Bertran E, Raimondi G et al. A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells. Int J Cancer 2015; 136: E161-E172.
58. Bertran E, Crosas-Molist E, Sancho P, Caja L, Lopez-Luque J, Navarro E et al. Overactivation of the TGF-beta pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells. Hepatology 2013; 58: 2032-2044.
59. Del Duca D, Werbowetski T, Del Maestro RF. Spheroid preparation from hanging drops: characterization of a model of brain tumor invasion. J Neurooncol 2004; 67: 295-303.
60. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6: pl1.
61. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2: 401-404.